Affordable Access

deepdyve-link
Publisher Website

Pharmacology of CCKRs and SAR studies of peptidic analog ligands.

Authors
Type
Published Article
Journal
Current Topics in Medicinal Chemistry
Publisher
Bentham Science
Publication Date
Jun 25, 2007
Volume
7
Issue
12
Pages
1173–1179
Identifiers
DOI: 10.2174/156802607780960447
PMID: 17584139
Source
USPC - SET - SVS
License
White

Abstract

Cholecystokinin (CCK) is a peptide originally discovered in the gastrointestinal tract but also found in high density in the mammalian brain. The C-terminal sulphated octapeptide fragment of cholecystokinin (CCK(8)) constitutes one of the major neuropeptides in the brain. CCK8, interacting with nanomolar affinities with two different receptors designated CCK1 and CCK2, has been shown to be involved in numerous physiological functions and is involved in the modulation/control of multiple central functions. In particular, CCK is involved in the neurobiology of anxiety, depression, psychosis, cognition, nociception and feeding behavior. The functional role of CCK has been facilitated thanks to the development of potent and selective CCK receptor antagonists and agonists. In this review, the strategies followed to design peptidic analog ligands will be reported, as the pharmacology of CCK receptors.

Report this publication

Statistics

Seen <100 times